Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting-Reference-Cited by-同舟云学术

Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting

Published:2020 Issue:1 Volume:61 Page:19
ISSN:2466-0493
Container-title:Investigative and Clinical Urology
language:en
Short-container-title:Investig Clin Urol

Author:

Jung Seung Il¹^ORCID,Kim Myung Soo¹^ORCID,Jeong Chang Wook²^ORCID,Kwak Cheol²^ORCID,Hong Sung Kyu³^ORCID,Kang Seok Ho⁴^ORCID,Joung Jae Young⁵^ORCID,Lee Seung Hwan⁶^ORCID,Yun Seok Joong⁷^ORCID,Kim Tae-Hwan⁸^ORCID,Park Sung Woo⁹^ORCID,Jeon Seong Soo¹⁰^ORCID,Kang Minyong¹⁰^ORCID,Lee Ji Youl¹¹^ORCID,Chung Byung Ha¹²^ORCID,Hong Jun Hyuk¹³^ORCID,Ahn Hanjong¹³^ORCID,Kim Choung-Soo¹³^ORCID,Kwon Dong Deuk¹^ORCID

Affiliation:

1. Department of Urology, Chonnam National University Medical School, Gwangju, Korea.

2. Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

3. Department of Urology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

4. Department of Urology, Korea University College of Medicine, Seoul, Korea.

5. Department of Urology, Center for Prostate Cancer, Korea National Cancer Center, Goyang, Korea.

6. Department of Urology, Severance Hospital, Yonsei University Health System, Seoul, Korea.

7. Department of Urology, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.

8. Department of Urology, Kyungpook National University School of Medicine, Daegu, Korea.

9. Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea.

10. Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

11. Department of Urology, The Catholic University of Korea, Seoul St. Mary Hospital's, College of Medicine, The Catholic University of Korea, Seoul, Korea.

12. Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

13. Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Publisher

The Korean Urological Association

Subject

Urology

Link

https://synapse.koreamed.org/pdf/10.4111/icu.2020.61.1.19

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide with versus Without Confirmatory Bone Scan;Cancer Research and Treatment;2023-12-05

2. Real-world outcomes for first line next-generation hormonal agents in metastatic prostate cancer: a systematic review;Future Oncology;2023-11

3. Novel hormonal therapies in the management of advanced prostate cancer: extrapolating Asian findings to Southeast Asia;BMC Urology;2023-01-06

4. Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide;Frontiers in Pharmacology;2022-05-19

5. Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study;Advances in Therapy;2022-04-10